Immunotoxins in the Therapy of Leukemias and Lymphomas
- 1 January 1991
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 9 (2) , 211-219
- https://doi.org/10.3109/07357909109044231
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal StudiesJNCI Journal of the National Cancer Institute, 1989
- Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemiaBlood, 1984
- Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.Journal of Clinical Oncology, 1984
- Pokeweed antiviral proteinPharmacology & Therapeutics, 1983
- Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemiaBlood, 1982
- Immunotoxins: Hybrid Molecules Combining High Specificity and Potent CytotoxicityImmunological Reviews, 1982
- Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cellsExperimental Cell Research, 1980
- Diphtheria ToxinAnnual Review of Biochemistry, 1977
- Ribosome Inactivation by the Toxic Lectins Abrin and RicinEuropean Journal of Biochemistry, 1975
- Mechanism of action of the toxic lectins abrin and ricinNature, 1974